Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver
Ruben Bill, Matteo Montani, Benedikt Blum, Jean‐François Dufour, Robert Escher, Michael Bühlmann – 23 February 2018